Oncolytics Biotech (ONCY) Institutional Ownership $0.79 -0.05 (-5.66%) As of 01/17/2025 04:00 PM Eastern Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Oncolytics Biotech (NASDAQ:ONCY)CurrentInstitutional OwnershipPercentage6.82%Number ofInstitutional Buyers(last 12 months)2TotalInstitutional Inflows(last 12 months)$170.96KNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$20.96K Get ONCY Insider Trade Alerts Want to know when executives and insiders are buying or selling Oncolytics Biotech stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data ONCY Institutional Buying and Selling by Quarter Oncolytics Biotech Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails1/8/2025 International Assets Investment Management LLC200,400$186K0.0%+15.0%0.259% 10/22/2024 International Assets Investment Management LLC174,331$152K0.0%-12.1%0.228% 5/20/2024Virtu Financial LLC51,889$55K0.0%N/A0.068% 1/24/2024 International Assets Investment Management LLC269,699$364K0.0%+33.9%0.362% 1/12/2024Advisor Resource Council100,000$135K0.0%N/A0.134% 1/11/2024Ausdal Financial Partners Inc.30,000$40K0.0%+50.0%0.041% 11/8/2023Ausdal Financial Partners Inc.20,000$44K0.0%N/A0.027% 10/13/2023 Brave Asset Management Inc.25,000$55K0.0%+150.0%0.035% 10/10/2023 International Assets Investment Management LLC201,453$449K0.0%+3.3%0.278% 10/4/2023 International Assets Investment Management LLC201,453$449K0.0%+3.3%0.278% Get the Latest News and Ratings for ONCY and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Oncolytics Biotech and its competitors with MarketBeat's FREE daily newsletter. 8/23/2023Headinvest LLC11,534$30K0.0%N/A0.016% 8/2/2023Bank of Montreal Can32,380$85K0.0%N/A0.049% 7/24/2023 Brave Asset Management Inc.10,000$26K0.0%N/A0.015% 7/20/2023 International Assets Investment Management LLC194,963$507K0.1%+3.4%0.297% 2/7/2023Lynwood Capital Management Inc.25,000$41K0.0%N/A0.041% 1/24/2023 International Assets Investment Management LLC169,111$609K0.1%-6.9%0.276% 1/20/2023Newman Dignan & Sheerar Inc.18,915$31K0.0%+46.5%0.031% 8/11/2022Toronto Dominion Bank35,362$34K0.0%N/A0.061% 7/27/2022Advisor Resource Council100,000$101K0.0%N/A0.173% 2/14/2022Long Focus Capital Management LLC40,000$56K0.0%N/A0.073% 2/11/2022Advisor Resource Council100,000$139K0.0%N/A0.182% 11/12/2021Renaissance Technologies LLC209,900$439K0.0%+812.6%0.382% 10/28/2021 International Assets Investment Management LLC170,576$357K0.1%+5.4%0.310% 10/7/2021Newman Dignan & Sheerar Inc.12,915$27K0.0%N/A0.023% 9/17/2021Virtu Financial LLC35,425$98K0.0%N/A0.064% 8/19/2021Advisor Resource Council101,000$280K0.0%N/A0.184% 8/13/2021Renaissance Technologies LLC23,000$64K0.0%N/A0.042% 8/12/2021JPMorgan Chase & Co.150,673$919K0.0%+167.7%0.274% 8/12/2021Bank of Montreal Can16,460$46K0.0%+40.1%0.030% 7/31/2021 Brave Asset Management Inc.20,000$55K0.0%+100.0%0.036% 5/21/2021Citadel Advisors LLC49,378$188K0.0%N/A0.093% 5/19/2021Chiron Capital Management LLC10,000$38K0.0%N/A0.019% 5/19/2021Squarepoint Ops LLC11,650$44K0.0%N/A0.022% 5/18/2021Citadel Advisors LLC49,378$188K0.0%N/A0.093% 5/17/2021Royal Bank of Canada27,381$105K0.0%-23.0%0.052% 5/17/2021Goldman Sachs Group Inc.10,300$39K0.0%N/A0.019% 5/12/2021Geode Capital Management LLC24,545$92K0.0%+51.4%0.046% 5/12/2021JPMorgan Chase & Co.56,283$214K0.0%N/A0.107% 5/11/2021Toronto Dominion Bank22,465$85K0.0%+190.5%0.043% 5/11/2021Banque Cantonale Vaudoise11,268$42K0.0%+723.7%0.021% 2025: Crypto Opportunities You Can’t Afford to Miss (Ad)Cryptocurrencies are once again gaining incredible momentum, and savvy investors are positioning themselves to capitalize on this surge in 2025. The question is—will you be among them? With groundbreaking advancements and increasing institutional adoption on the horizon, there's never been a better time to explore the potential gains in crypto. What’s Fueling the Crypto Comeback?Get our comprehensive guide, Navigating the Future: Cryptos to Watch in 20254/26/2021 Brave Asset Management Inc.10,000$38K0.0%N/A0.019% 4/19/2021 International Assets Investment Management LLC277,852$885K0.1%+130.1%0.533% 2/24/2021Virtu Financial LLC19,587$47K0.0%N/A0.047% 2/10/2021Renaissance Technologies LLC174,220$415K0.0%+1,284.3%0.418% 1/29/2021Creative Planning180,000$428K0.0%+5.9%0.390% 1/22/2021 International Assets Investment Management LLC120,776$287K0.1%+29.3%0.290% (Data available from 1/1/2016 forward) ONCY Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of ONCY shares? During the previous two years, the following institutional investors and hedge funds held shares of Oncolytics Biotech shares: International Assets Investment Management LLC ($186K), Advisor Resource Council ($135K), Bank of Montreal Can ($85K), Virtu Financial LLC ($55K), Brave Asset Management Inc. ($55K), Lynwood Capital Management Inc. ($41K), and Ausdal Financial Partners Inc. ($40K).Learn more on ONCY's institutional investors. What percentage of Oncolytics Biotech stock is owned by institutional investors? 6.82% of Oncolytics Biotech stock is owned by institutional investors. Learn more on ONCY's institutional investor holdings. Which institutional investors have been buying Oncolytics Biotech stock? The following institutional investors have purchased Oncolytics Biotech stock in the last 24 months: International Assets Investment Management LLC ($113.64K), Advisor Resource Council ($100K), Virtu Financial LLC ($51.89K), Bank of Montreal Can ($32.38K), Ausdal Financial Partners Inc. ($30K), Brave Asset Management Inc. ($25K), and Lynwood Capital Management Inc. ($25K). How much institutional buying is happening at Oncolytics Biotech? Institutional investors have bought a total of 389,438 shares in the last 24 months. This purchase volume represents approximately $621.46K in transactions. Which Oncolytics Biotech major shareholders have been selling company stock? The following institutional investors have sold Oncolytics Biotech stock in the last 24 months: International Assets Investment Management LLC ($36.53K). How much institutional selling is happening at Oncolytics Biotech? Institutional investors have sold a total of 36,534 shares in the last 24 months. This volume of shares sold represents approximately $41.28K in transactions. Related Companies AC Immune Institutional Ownership Canopy Growth Institutional Ownership Candel Therapeutics Institutional Ownership Benitec Biopharma Institutional Ownership C4 Therapeutics Institutional Ownership Foghorn Therapeutics Institutional Ownership UroGen Pharma Institutional Ownership Lifecore Biomedical Institutional Ownership Atai Life Sciences Institutional Ownership Eledon Pharmaceuticals Institutional Ownership This page (NASDAQ:ONCY) was last updated on 1/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe crypto bull market is here, and the stakes couldn’t be higher. The next 3-6 months? They’re the most ex...Crypto Swap Profits | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredElon’s New AI Firm REVEALEDNvidia’s AI chip … the H100 … has been the holy grail of artificial intelligence… Until now. Because Elo...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oncolytics Biotech Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Oncolytics Biotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ONCY Stock Alerts